Exposure to Mixtures of Metals and Neurodevelopmental Outcomes: A Multidisciplinary Review Using an Adverse Outcome Pathway Framework

Risk Analysis

Volumn 35, Issue 6, 2015, Pages 971-1016

  von Stackelberg, Katherine ^a,b   Guzy, Elizabeth ^b   Chu, Tian ^b   Henn, Birgit Claus ^b,c  

^a HARVARD CENTER FOR RISK ANALYSIS   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adverse outcome pathway; Arsenic; Cadmium; Developmental; Lead; Manganese; Metal mixtures; Systematic review

Indexed keywords

AIR NAVIGATION; ARSENIC; LEAD; MANGANESE; METALS; MIXTURES; RISK ASSESSMENT;

ADVERSE OUTCOMES; DEVELOPMENTAL; ENVIRONMENTAL MIXTURES; METAL MIXTURES; MULTIPLE DATA SOURCES; MULTIPLE DISCIPLINES; ORGANIZATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT; SYSTEMATIC REVIEW;

CADMIUM;

METAL;

CHEMICALLY INDUCED; ENVIRONMENTAL EXPOSURE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MENTAL DISEASE; RISK ASSESSMENT;

ENVIRONMENTAL EXPOSURE; GENE-ENVIRONMENT INTERACTION; HUMANS; METALS; NEURODEVELOPMENTAL DISORDERS; RISK ASSESSMENT;

EID: 84937073879     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/risa.12425     Document Type: Note

References (188)

1. MacDonell MM, Haroun LA, Teuschler LK, Rice GE, Hertzberg RC, Butler JP, Chang Y-S, Clark SL, John AP, Perry CS, Garcia SS, Jacob JH, Scofield MA. 2013. Cumulative risk assessment toolbox: Methods and approaches for the practitioner. Journal of Toxicology, 2013; Article ID 310904, doi:10.1155/2013/310904.
2. Backhaus T, Faust M. Predictive environmental risk assessment of chemical mixtures: A conceptual framework. Environmental Science & Technology, 2012; 46(5):2564-2573.
3. International Programme on Chemical Safety (IPCS), World Health Organization (WHO). Assessment of combined exposures to multiple chemicals. Report of a WHO/IPCS International Workshop, 2009.
4. Claus Henn B, Coull BA, Wright RO. Chemical mixtures and children's health. Current Opinion in Pediatrics, 2014; 26:223-229.
5. Roy A, Ettinger AS, Hu H, Bellinger D, Schwartz J, Modali R, Wright RO, Palaniappan K, Balakrishnan K. Effect modification by transferrin C2 polymorphism on lead exposure, hemoglobin levels, and IQ. Neurotoxicology, 2013; 38C:17-22.
6. Hopkins MR, Ettinger AS, Hernandez-Avila M, Schwartz J, Tellez-Rojo MM, Lamadrid-Figueroa H, Bellinger D, Hu H, Wright RO. Variants in iron metabolism genes predict higher blood lead levels in young children. Environmental Health Perspectives, 2008; 116(9):1261-1266.
7. Wang FT, Hu H, Schwartz J, Weuve J, Spiro AS, III, Sparrow D, Nie H, Silverman EK, Weiss ST, Wright RO. Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive decline. Environmental Health Perspectives, 2007; 115(8):1210-1215.
8. Claus Henn B, Kim J, Wessling-Resnick M, Maria Tellez-Rojo M, Jayawardene I, Ettinger AS, Hernandez-Avila M, Schwartz J, Christiani DC, Hu H, Wright RO. Associations of iron metabolism genes with blood manganese levels: A population-based study with validation data from animal models. Environmental Health, 2011; 10:97.
9. Gundacker C, Gencik M, Hengstschläger M. The relevance of the individual genetic background for the toxicokinetics of two significant neurodevelopmental toxicants: Mercury and lead. Mutation Research, 2010; 705(2):130-140.
10. Gu C, Chen S, Xu X, Zheng L, Li Y, Wu K, Liu J, Qi Z, Han D, Chen G, Huo, X. Lead and cadmium synergistically enhance the expression of divalent metal transporter 1 protein in central nervous system of developing rats. Neurochemical Research, 2009; 34(6):1150-1156.
11. Nigg JT, Knottnerus GM, Martel MM, Nikolas M, Cavanagh K, Karmaus W, Rappley MD. Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control. Biological Psychiatry, 2008; 63(3):325-331.
12. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Lead. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, 2007.
13. Wasserman GA, Liu X, Parvez F, Factor-Litvak P, Ahsan H, Levy D, Kline J, van Geen A, Mey J, Slavkovich V, Siddique AB, Islam T, Graziano JH. Arsenic and manganese exposure and children's intellectual function. Neurotoxicology, 2011; 32(4):450-457.
14. Kim Y, Kim BN, Hong YC, Shin MS, Yoo HJ, Kim JW, Bhang SY, Cho SC. Co-exposure to environmental lead and manganese affects the intelligence of school-aged children. Neurotoxicology, 2009; 30(4):564-571.
15. Wright RO, Amarasiriwardena C, Woolf AD, Jim R, Bellinger DC. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology, 2006; 27(2):210-216.
16. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Manganese. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, 2012.
17. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Arsenic. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, 2007.
18. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Cadmium. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, 2012.
19. Agency for Toxic Substances and Disease Registry (ATSDR). Interaction Profile for Arsenic, Cadmium, Chromium and Lead. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, 2004.
20. Pohl HR, Roney N, Wilbur S, Hansen H, De Rosa CT. Six interaction profiles for simple mixtures. Chemosphere, 2003; 53(2):183-197.
21. ATSDR. Guidance Manual for the Assessment of Joint Toxic Action of Chemical Mixtures. Atlanta, GA: Agency for Toxic Substances and Disease Registry, 2001.
22. ATSDR. Guidance Manual for the Preparation of an Interaction Profile. Atlanta, GA: Agency for Toxic Substances and Disease Registry, 2001.
23. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA et al. The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. Journal of Toxicology, 2009; Article ID 532640, doi:10.1155/2009/532640.
24. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in US children. Environmental Health Perspectives, 2006; 114(12):1904-1909.
25. Amler RW, Barone Jr. S, Belger A, Berlin Jr. CM, Cox C, Frank H, Goodman M, Harry J, Hooper SR, Ladda R, LaKind JS, Lipkin PH, Lipsitt LP, Lorber MN, Myers G, Mason AM, Needham LL, Sonawane B, Wachs TD, Yager JW. Hershey Medical Center Technical Workshop Report: Optimizing the design and interpretation of epidemiologic studies for assessing neurodevelopmental effects from in utero chemical exposure. NeuroToxicology, 2006; 27:861-874.
26. Mennenga SE, Baxter LC, Grunfeld IS, Brewer GA, Aiken LS, Engler-Chiurazzi EB, Camp BW, Acosta JI, Braden BB, Schaefer KR, Gerson JE, Lavery CN, Tsang CW, Hewitt LT, Kingston ML, Koebele SV, Patten KJ, Ball BH, McBeath MK, Bimonte-Nelson HA. Navigating to new frontiers in behavioral neuroscience: Traditional neuropsychological tests predict human performance on a rodent-inspired radial-arm maze. Frontiers in Behavioral Neuroscience, 2014; 8:294.
27. Organisation for Economic Co-operation and Development (OECD). Report of the workshop on using mechanistic information in forming chemical categories, Series on Testing and Assessment, No. 138, ENV/JM/MONO(2011)8, 2011.
28. Organisation for Economic Co-operation and Development (OECD). Guidance document on developing and assessing adverse outcome pathways, Series on Testing and Assessment, No. 184, ENV/JM/MONO(2013)6, 2013.
29. Meek ME, Palermo CM, Bachman AN, North CM, Lewis RJ. Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. Journal of Applied Toxicology, 2014; 34:596-606.
30. Organisation for Economic Co-operation and Development (OECD). Users' handbook supplement to the guidance document for developing and assessing AOPs, 2014. Available at: www.aopwiki.org, Accessed October 2014.
31. Ben Fredj F, Irie M, Han J, Yamada P, Limam A, Ghrabi A, Morio T, Isoda H. Stress response of heavy metal mixture present in wastewater and leachate on heat-shock protein 47-transfected cells. Environmental Toxicology and Chemistry, 2010; 29(7):1637-1647.
32. Carfagna MA, Ponsler GD, Muhoberac BB. Inhibition of ATPase activity in rat synaptic plasma membranes by simultaneous exposure to metals. Chemico-Biological Interactions, Chemico-Biol Interact, 1996; 100(1):53-65.
33. +-ATPase and the uptake of H3-DA and H3-NA in rat-brain synaptosomes. Acta Pharmacol Toxicol, 1984; 54(3):210-213.
34. +-ATPase in striatal synaptosomes. Journal of Applied Toxicology, 1987; 7(4):277-280.
35. Kalia K, Chandra SV, Viswanathan PN. Effect of 54Mn and lead interaction on their binding with tissue proteins: In vitro studies. Industrial Health, 1984; 22(3):207-218.
36. Lai JCK, Guest JF, Leung TKC, Lim L, Davison AN. Effects of cadmium, manganese and aluminum on sodium-potassium-activated and magnesium-activated adenosine-triphosphatase activity and choline uptake in rat-brain synaptosomes. Biochemical Pharmacology, 1980; 29(2):141-146.
37. 3+ on the uptake of dopamine by synaptosomes from forebrain and from striatum of the rat. Biochemical Pharmacology, 1981; 30(22):3123-3125.
38. Antonio MT, Lopez N, Leret ML. Pb and Cd poisoning during development alters cerebellar and striatal function in rats. Toxicology, 2002; 176(1-2):59-66.
39. Nation JR, Grover CA, Bratton GR, Salinas JA. Behavioral antagonism between lead and cadmium. Neurotoxicology and Teratology, 1990; 12(2):99-104.
40. Leret ML, San Millan JA, Antonio MT. Perinatal exposure to lead and cadmium affects anxiety-like behaviour. Toxicology, 2003; 186(1-2):125-130.
41. Bizarro P, Acevedo S, Niño-Cabrera G, Mussali-Galante P, Pasos F, Avila-Costa MR, Fortoul TI. Ultrasturctural modifications in the mitochondrion of mouse Sertoli cells after inhalation of lead, cadmium, or lead-cadmium mixture. Reproductive Toxicology, 2003; 17(5):561-566.
42. Zhang Y-M, Liu X-Z, Lu H, Mei L, Liu Z-P. Lipid peroxidation and ultrastructural modifications in brain after perinatal exposure to lead and/or cadmium in rat pups. Biomedical and Environmental Sciences, 2009; 22(5):423-429.
43. Nampoothiri LP, Gupta S. Biochemical effects of gestational coexposure to lead and cadmium on reproductive performance, placenta, and ovary. Journal of Biochemical and Molecular Toxicology, 2008; 22(5):337-344.
44. Pillai P, Patel R, Pandya C, Gupta S. Sex-specific effects of gestational and lactational coexposure to lead and cadmium on hepatic phase i and phase ii xenobiotic/steroid-metabolizing enzymes and antioxidant status. Journal of Biochemical and Molecular Toxicology, 2009; 23(6):419-431.
45. Pillai P, Pandya C, Gupta S, Gupta S. Biochemical and molecular effects of gestational and lactational coexposure to lead and cadmium on ovarian steroidogenesis are associated with oxidative stress in F1 generation rats. Journal of Biochemical and Molecular Toxicology, 2010; 24(6):384-394.
46. Pillai A, Laxmi Priya PN, Gupta S. Effects of combined exposure to lead and cadmium on pituitary membrane of female rats. Archives of Toxicology, 2002; 76(12):671-675.
47. Pillai A, Priya L, Gupta S. Effects of combined exposure to lead and cadmium on the hypothalamic-pituitary axis function in proestrous rats. Food and Chemical Toxicology, 2003; 41(3):379-84.
48. Smith E, Gancarz D, Rofe A, Kempson IM, Weber J, Juhasz AL. Antagonistic effects of cadmium on lead accumulation in pregnant and non-pregnant mice. Journal of Hazardous Materials, 2012; 199-200:453-456.
49. Betharia S, Maher TJ. Neurobehavioral effects of lead and manganese individually and in combination in developmentally exposed rats. Neurotoxicology, 2012; 33(5):1117-1127.
50. Chandra AV, Ali MM, Saxena DK, Murthy RC. Behavioral and neurochemical changes in rats simultaneously exposed to manganese and lead. Archives of Toxicology, 1981; 49(1):49-56.
51. Chandra SV, Murthy RC, Saxena DK, Lal B. Effects of pre natal and post natal combined exposure to lead and manganese on brain development in rats. Industrial Health, 1983; 21(4):273-280.
52. Malhotra KM, Murthy RC, Srivastava RS, Chandra SV. Concurrent exposure of lead and manganese to iron-deficient rats-Effect on lipid-peroxidation and contents of some metals in the brain. Journal of Applied Toxicology, 1984; 4(1):22-25.
53. Fairhall LT, Miller JW. A study of the relative toxicity of the molecular components of lead arsenate. Public Health Reports, 1941; 56(32):1610-1625.
54. Mejía JJ, Diaz Barriga F, Calderon J, Rios C, Jimenez, Capdeville ME. Effects of lead-arsenic combined exposure on central monoaminergic systems. Neurotoxicology and Teratology, 1997; 19(6):489-497.
55. Sannadi S, Kadeyalaa PK, Gottipolu RR. Reversal effect of monoisoamyl dimercaptosuccinic acid (MiADMSA) for arsenic and lead induced perturbations in apoptosis and antioxidant enzymes in developing rat brain. International Journal of Developmental Neuroscience, 2013; 31:586-597.
56. Diacomanolis V, Noller BN, Ng JC. Interaction effects of lead on bioavailability and pharmacokinetics of arsenic in the rat. Environmental Geochemistry and Health, 2013; 35:757-766.
57. Hochadel JF, Waalkes MP. Sequence of exposure to cadmium and arsenic determines the extent of toxic effects in male Fischer rats. Toxicology, 1997; 116(1-3):89-98.
58. Lai S, Gupta SK, Chandra SV. The effect of manganese administration, alone or combined with zinc, mercury and cadmium, on the tissue-levels of these elements in rats. Toxicology Letters, 1980; 5(3-4):203-206.
59. 2+ on some neurochemicals in rats. Toxicology Letters, 1982; 10(2-3):163-168.
60. Rai A, Tripathi S, Kushwaha R, Singh P, Srivastava P, Sanyal S, Bandyopadhyay S. CDK5-induced p-PPARc(Ser 112) downregulates GFAP via PPREs in developing rat brain: Effect of metal mixture and troglitazone in astrocytes. Cell Death & Differentiation, 2014; 5:e1033, doi:10.1038/cddis.2013.514.
61. Rai NK, Ashok A, Rai A, Tripathi S, Nagar GK, Mitra K, Bandyopadhyay S. Exposure to As, Cd and Pb-mixture impairs myelin and axon development in rat brain, optic nerve and retina. Toxicology and Applied Pharmacology, 2013; 273:242-258.
62. Rai A, Maurya SK, Sharma R, Ali S. Down-regulated GFAPα: A major player in heavy metal induced astrocyte damage. Toxicology Mechanisms and Methods, 2013; 23(2):99-107.
63. Rai A, Maurya SK, Khare P, Srivastava A, Bandyopadhyay S. Characterization of developmental neurotoxicity of As, Cd, and Pb mixture: Synergistic action of metal mixture in glial and neuronal functions. Toxicological Sciences, 2010; 118(2):586-601.
64. Fowler BA, Whittaker MH, Lipsky M, Wang GS, Chen XQ. Oxidative stress induced by lead, cadmium and arsenic mixtures: 30-day, 90-day, and 180-day drinking water studies in rats: An overview. Biometals, 2004; 17(5):567-568.
65. Mahaffey KR, Fowler BA. Effects of concurrent administration of lead, cadmium, and arsenic in rat. Environmental Health Perspectives, 1977; 19(Aug):165-171.
66. Mahaffey KR, Capar SG, Gladen BC, Fowler BA. Concurrent exposure to lead, cadmium, and arsenic-Effects on toxicity and tissue metal concentrations in the rat. Journal of Laboratory and Clinical Medicine, 1981; 98(4):463-481.
67. Andrade V, Mateus ML, Santos D, Aschner M, Batoréu MC, Marreilha dos Santos AP. Arsenic and manganese alter lead deposition in the rat. Biological Trace Element Research, 2014; 158:384-391.
68. Andrade V, Mateus ML, Batoréu MC, Aschner M, dos Santos AP. Urinary delta-ALA: A potential biomarker of exposure and neurotoxic effect in rats co-treated with a mixture of lead, arsenic and manganese. Neurotoxicology, 2013; 38:33-41.
69. Shukla GS, Chandra SV. Concurrent exposure to lead, manganese, and cadmium and their distribution to various brain-regions, liver, kidney, and testis of growing-rats. Archives of Environmental Contamination and Toxicology, 1987; 16(3):303-310.
70. Rodriguez VM, Dufour L, Carrizales L, Diaz-Barriga F, Jimenez-Capdeville ME. Effects of oral exposure to mining waste on in vivo dopamine release from rat striatum. Environmental Health Perspectives, 1998; 106(8):487-491.
71. Elsenhans B, Schmolke G, Kolb K, Stokes J, Forth W. Metal metal interactions among dietary toxic and essential trace-metals in the rat. Ecotoxicology and Environmental Safety, 1987; 14(3):275-287.
72. Jadhav SH, Sarkar SN, Aggarwal M, Tripathi HC. Induction of oxidative stress in erythrocytes of male rats subchronically exposed to a mixture of eight metals found as groundwater contaminants in different parts of India. Archives of Environmental Contamination and Toxicology, 2007; 52(1):145-151.
73. Chandra SV, Shukla GS, Srivastava RS, Gupta SK. Combined effect of metals on biogenic-amines and their distribution in the brain of mice. Archives of Environmental Contamination and Toxicology, 1980; 9(1):79-85.
74. Geier DA, Kern JK, King PG, Sykes LK, Geier MR. Hair toxic metal concentrations and autism spectrum disorder severity in young children. International Journal of Environmental Research and Public Health, 2012; 9(12):4486-4497.
75. Haynes EN, Chen A, Ryan P, Succop P, Wright J, Dietrich KN. Exposure to airborne metals and particulate matter and risk for youth adjudicated for criminal activity. Environmental Research, 2011; 111:1243-1248.
76. Marlowe M, Cossairt A, Moon C, Errera J, Macneel A, Peak R, Ray J, Schroeder C. Main and interaction effects of metallic toxins on classroom-behavior. Journal of Abnormal Child Psychology, 1985a; 13(2):185-198.
77. Marlowe M, Stellern J, Errera J, Moon C. Main and interaction effects of metal pollutants on visual-motor performance. Archives of Environmental Health, 1985b; 40(4):221-225.
78. Moon C, Marlowe M, Stellern J, Errera J. Main and interaction effects of metallic pollutants on cognitive-functioning. Journal of Learning Disabilities, 1985; 18(4):217-221.
79. Lin C-C, Chen Y-C, Su F-C, Lin C-M, Liao H-F, Hwang Y-H, Hsieh W-S, Jeng S-F, Su Y-N, Chen P-C. In utero exposure to environmental lead and manganese and neurodevelopment at 2 years of age. Environmental Research, 2013; 123:52-57.
80. McDermott S, Wu J, Cai B, Lawson A, Marjorie Aelion C. Probability of intellectual disability is associated with soil concentrations of arsenic and lead. Chemosphere, 2011; 84:31-38.
81. Calderón J, Navarro ME, Jimenez-Capdeville ME, Santos-Diaz MA, Golden A, Rodriguez-Levya I, Borja-Aburto V, Diaz-Barriga F. Exposure to arsenic and lead and neuropsychological development in Mexican children. Environmental Research, 2001; 85(2):69-76.
82. Obrenovich ME, Shamberger RJ, Lonsdale D. 2011. Altered heavy metals and transketolase found in autistic spectrum disorder. Biological Trace Element Research, 2011; 144(1-3):475-486.
83. Parajuli RP, Fujiwara T, Umezaki M, Watanabe C. Association of cord blood levels of lead, arsenic, and zinc with neurodevelopmental indicators in newborns: A birth cohort study in Chitwan Valley, Nepal. Environmental Research, 2013; 121:45-51.
84. Rosado JL, Ronquillo D, Kordas K, Rojas O, Alatorre J, Lopez P, Garcia-Vargas G, Del Carmen Caamano M, Cebrian ME, Stoltzfus RJ. Arsenic exposure and cognitive performance in Mexican schoolchildren. Environmental Health Perspectives, 2007; 115(9):1371-1375.
85. Kim Y, Ha EH, Park H, Ha M, Kim Y, Hong YC, Kim EJ, Kim BN. Prenatal lead and cadmium co-exposure and infant neurodevelopment at 6 months of age: The Mothers and Children's Environmental Health (MOCEH) study. Neurotoxicology, 2013; 35:15-22.
86. Lee DH, Lim JS, Song K, Boo Y, Jacobs DR. 2006. Graded associations of blood lead and urinary cadmium concentrations with oxidative-stress-related markers in the US population: Results from the Third National Health and Nutrition Examination Survey. Environmental Health Perspectives, 2006; 114(3):350-354.
87. Thatcher RW, Lester ML, McAlaster R, Horst R. Effects of low-levels of cadmium and lead on cognitive-functioning in children. Archives of Environmental Health, 1982; 37(3):159-166.
88. Claus Henn B, Schnaas L, Ettinger AS, Schwartz J, Lamadrid-Figueroa H, Hernandez- Avila M, Amarasiriwardena C, Hu H, Bellinger DC, Wright RO, Tellez-Rojo, MM. Associations of early childhood manganese and lead coexposure with neurodevelopment. Environmental Health Perspectives, 2012; 120(1):126-131.
89. Lucchini RG, Zoni S, Guazzetti S, Bontempi E, Micheletti S, Broberg K, Parrinello G, Smith DR. Inverse association of intellectual function with very low blood lead but not with manganese exposure in Italian adolescents. Environmental Research, 2012; 118:65-71.
90. Roberts AL, Lyall K, Hart JE, Laden F, Just AC, Bobb JF, Koenen KC, Ascherio A, Weisskopf MG. Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses' Health Study II participants. Environmental Health Perspectives, 2013; 121(8):978-984.
91. Khan K, Factor-Litvak P, Wasserman GA, Liu XH, Ahmed E, Parvez F, Slavkovich V, Levy D, Mey J, van Geen A, Graziano JH. Manganese exposure from drinking water and children's classroom behavior in Bangladesh. Environmental Health Perspectives, 2011; 119(10):1501-1506.
92. Yang C-S, Tzou B-C, Liu Y-P, Tsai M-J, Shyue S-K, Tzeng S-F. Inhibition of cadmium-induced oxidative injury in rat primary astrocytes by the addition of antioxidants and the reduction of intracellular calcium. Journal of Cellular Biochemistry, 2008; 103(3):825-834.
93. Ishitobi H, Mori K, Yoshida K, Watanabe C. Effects of perinatal exposure to low-dose cadmium on thyroid hormone-related and sex hormone receptor gene expressions in brain of offspring. Neurotoxicology, 2007; 28(4):790-797.
94. Lamb MR, Janevic T, Liu X, Cooper T, Kline J, Factor-Litvak P. Environmental lead exposure, maternal thyroid function, and childhood growth. Environmental Research, 2008; 106(2):195-202.
95. Henson MC, Chedrese PJ. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Experimental Biology and Medicine, 2004; 229:383-392.
96. Lidsky TI, Schneider JS. Review Article. Lead neurotoxicity in children: Basic mechanisms and clinical correlates. Brain, 2003; 126:5-19.
97. 2+): Effects on synaptic function. Molecular Neurobiology, 2010; 42:151-160.
98. Aschner M, Guilarte TR, Schneider JS, Zheng W. Manganese: Recent advances in understanding its transport and neurotoxicity. Toxicology and Applied Pharmacology, 2007; 221:131-147.
99. Khalid M, Aoun RA, Mathews TA. Altered striatal dopamine release following a sub-acute exposure to manganese. Journal of Neuroscience Methods, 2011; 202:182-191.
100. Claus Henn B, Ettinger AS, Schwartz J, Maria Tellez-Rojo M, Lamadrid-Figueroa H, Hernandez-Avila M, Schnaas L, Amarasiriwardena C, Bellinger DC, Hu H, Wright RO. Early postnatal blood manganese levels and children's neurodevelopment. Epidemiology, 2010; 21(4):433-439.
101. Zarembski PM, Griffiths PD, Walker J, Goodall HB. Lead in neonates and mothers. Clinica Chimica Acta, 1983; 134:35-49.
102. Ong CN, Phoon WO, Law HY, Tye CY, Lim HH. Concentrations of lead in maternal blood, cord blood, and breast milk. Archives of Disease in Childhood, 1985; 60:756-759.
103. Hoffman K, Becker K, Friedrich C, Helm D, Krause C, Seifert B. The German Environmental Survey 1990/1992 (GerES II): Cadmium in blood, urine, and hair of adults and children. Journal of Exposure Analysis and Environmental Epidemiology, 2000; 10:126-135.
104. Shraim A, Cui X, Li S, Ng JC, Wang J, Jin Y, Liu Y, Guo L, Li D, Wang S, Zhang R, Seishiro H. 2003. Arsenic speciation in the urine and hair of individuals exposed to airborne arsenic through coal-burning in Guizhou, PR China. Toxicology Letters, 2003; 137:35-48.
105. Chen L, Ding G, Gao Y, Wang P, Shi R, Huang H, Tian Y. Manganese concentrations in maternal-infant blood and birth weight. Environmental Science and Pollution Research, 2014; 21(9):6170-6175.
106. Rodrigues JL, Batista BL, Nunes JA, Passos CJS, Barboa F Jr. Evaluation of the use of human hair for biomonitoring the deficiency of essential and exposure to toxic elements. Science of the Total Environment, 2008; 405:370-376.
107. Mora AM, van Wendel de Joode B, Mergler D, Córdoba L, Cano C, Quesada R, Smith DR, Menenez-Filho JA, Lundh T, Lindh CH, Bradman A, Eskenazi B. Blood and hair manganese concentrations in pregnant women from the infants' environmental health study (ISA) in Costa Rica. Environmental Science & Technology, 2014; 48:3467-3476.
108. Ayotte JD, Montgomery DL, Flanagan SM, Robinson KW. Arsenic in groundwater in eastern New England: Occurrence, controls, and human health implications. Environmental Science & Technology, 2003; 7(10):2075-2083.
109. Hu H, Shine J, Wright RO. The challenge posed to children's health by mixtures of toxic waste: The Tar Creek superfund site as a case-study. Pediatric Clinics of North America, 2007; 54(1):155-175.
110. Naess O, Piro FN, Nafstad P, Smith GD, Leyland AH. Air pollution, social deprivation, and mortality: A multilevel cohort study. Epidemiology, 2007; 18(6):686-694.
111. Yamada K, Mizuno M, Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Science, 2002; 70:735-744.
112. 2+: Implications for an environmental basis of neurodevelopmental disorders. Toxicological Sciences, 2012; 127(1):277-295.
113. Mattson M. Apoptosis in neurodegenerative disorders 2000. Nature Reviews Molecular Cell Biology, 2000; 1:120-129.
114. Folch J, Alvira D, Lopez-Querol M, Tajes M, Sureda FX, Forsby A, Rimbau V, Camins A, Pallas M. Evaluation of transcriptional activity of caspase-3 gene as a marker of acute neurotoxicity in rat cerebellar granular cells. Toxicology in Vitro, 2010; 24(2):465-471.
115. D'Amelio M, Cavallucci V, Cecconi F. Review. Neuronal caspase-3 signaling: Not only cell death. Cell Death Different, 2010; 17:1104-1114.
116. Syapin P. Review. Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. British Journal of Pharmacology, 2008; 155:623-640.
117. Pearson G, Robinson F, Gibson TB, Xu B-E, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocrine Reviews, 2001; 22(2):153-183.
118. Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: Cause, effect, or association? Journal of Clinical Investigation, 2003; 111:163-169.
119. Samuels IS, Saitta SC, Landreth GE. MAP'ing CNS development and cognition: An ERKsome process. Neuron, 2009; 61(2):160-167.
120. Lee WC, Choi CH, Cha SH, Oh HL, Kim YK. Role of ERK in hydrogen peroxide-induced cell death of human glioma cells. Neurochemical Research, 2005; 30(2): 263-270,
121. Lu T-H, Tseng T-J, Su C-C, Tang F-C, Yen C-C, Liu Y-Y, Yang C-Y, Wu C-C, Chen K-L, Hung D-Z, Chen Y-W. Arsenic induces reactive oxygen species-caused neuronal cell apoptosis through JNK/ERK-mediated mitochondria-dependent and GRP 78/CHOP-regulated pathways. Toxicology Letters, 2014; 224(1):130-140.
122. 38MAPK. NeuroToxicol, 2008; 29:727-734.
123. Méndez-Armenta M, Ríos C. Mini review. Cadmium neurotoxicity. Environmental Toxicology and Pharmacology, 2007; 23:350-358
124. Wang B, Du Y. Cadmium and its neurotoxicity. Review article. Oxidative Medicine and Cellular Longevity, 2013, Article ID 898034, http://dx.doi.org/10.1155/2013/898034.
125. Cordova FM, Aguiar AS, Peres TV, Lopes MW Gonçalves FM, Remor AP, Lopes SC, Pilati C, Latini AS, Prediger RDS, Erikson KM, Aschner M, Leal RB. In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function. PLoS One, 2012; 7(3):e33057.
126. Filipov NM, Dodd CA. Role of glial cells in manganese neurotoxicity. Journal of Applied Toxicology, 2012; 32(5):310-317. doi: 10.1002/jat.1762.
127. Crittenden PL, Filipov NM. Manganese modulation of MAPK pathways: Effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells. Journal of Applied Toxicology, 2011; 31(1):1-10.
128. Cordova FM, Rodrigues AL, Giacomelli MB, Oliveira CS, Posser T, Dunkley PR, Leal RB. Lead stimulates ERK1/2 and p38MAPK phosphorylation in the hippocampus of immature rats. Brain Research, 2004; 998(1):65-72.
129. Wang JY, Shum AYC, Ho YJ, Wang JY. Oxidative neurotoxicity in rat cerebral cortex neurons: Synergistic effects of H2O2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. Journal of Neuroscience Research, 2003; 72(4):508-519.
130. Lohmann C. Calcium signaling and the development of specific neuronal connections. Progress in Brain Research, 2009; 175:443-452.
131. Michaelson K, Lohmann C. Calcium dynamics at developing synapses: Mechanisms and functions. European Journal of Neuroscience, 2010; 32:218-223.
132. Navarette M, Perea G, Maglio L, Pastor J, de Sola RG, Araque A. Astrocyte calcium signal and gliotransmission in human brain tissue. Cerebral Cortex, 2013; 23:1240-1246.
133. 2+ signalling: An unexpected complexity. Nature Reviews Neuroscience, 2014; 15:327-335,
134. Barker AJ, Ullian EM. New roles for astrocytes in developing synaptic circuits. Communicative & Integrative Biology, 2008; 1(2):207-211.
135. Vahidnia A, van der Voet GB, de Wolff FA. Arsenic neurotoxicity-A review. Human & Experimental Toxicology, 2007; 26:823-832.
136. Rocha RA, Gimeno-Alcaniz JV, Martin-Ibanez R, Canals JM, Velez D, Devesa V. Arsenic and fluoride induce neural progenitor cell apoptosis. Toxicology Letters, 2011; 203(3):237-244.
137. Chattopadhyay S, Bhaumik S, Chaudhury AN, Das Gupta S. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicology Letters, 2002; 128(1-3):73-84.
138. Chattopadhyay S, Bhaumik S, Purkayastha M, Basu S, Chaudhury AN, Das Gupta S. Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicology Letters, 2002; 136(1):65-76.
139. Yuan Y, Jiang CY, Xu H, Sun Y, Hu FF, Bian JC, Liu XZ, Gu JH, Liu ZP. Cadmium-induced apoptosis in primary rat cerebral cortical neurons culture is mediated by a calcium signaling pathway. PLoS One, 2013; 8(5):e64330.
140. Yen CC, Ho TJ, Wu CC, Chang CF, Su CC, Chen YW, Jinn TR, Lu TH, Cheng PW, Su YC, Liu SH, Huang CF. Inorganic arsenic causes cell apoptosis in mouse cerebrum through an oxidative stress-regulated signaling pathway. Archives of Toxicology, 2011; 85(6):565-575.
141. Bellinger D. Inorganic arsenic exposure and children's neurodevelopment: A review of the evidence. Toxics, 2013; 1:2-17.
142. Zhang J, Liu X, Zhao L, Hu S, Lis S, Piao F. Subchronic exposure to arsenic disturbed the biogenic amine neurotransmitter level and the mRNA expression of synthetase in mice brains. Neuroscience, 2013; 241:52-58.
143. Neal AP, Guilarte TR. Mechanisms of heavy metal neurotoxicity: Lead and manganese. Drug Metabolism & Toxicology, 2012; S5 http://dx.doi.org/10.4172/2157-7609.S5-002.
144. Hazell AS. Astrocytes and manganese neurotoxicity. Neurochemistry International, 2002; 41:271-277.
145. Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochemical Research, 2000; 25(9-10):1439-1451.
146. Middeldorp J, Hol EM. GFAP in health and disease. Progress in Neurobiology, 2011; 93:421-443.
147. Stevens B. Neuron-astrocyte signaling in the development and plasticity of neural circuits. Neurosignals, 2008; 16:278-288.
148. Clarke LE, Barres BA. Emerging roles of astrocytes in neural circuit development. Nature Reviews Neuroscience, 2013; 14:311-321.
149. Sun W, McConnell E, Pare J-F, Xu Q, Chen M, Peng W, Lovatt D, Han X, Smith Y, Nedergaard M. Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. Science, 2013; 339:197-200.
150. Covelo A, Araque A. Lateral regulation of synaptic transmission by astrocytes. Neuroscience, 2015; Feb 27. pii: S0306-4522(15)00188-8. doi: 10.1016/j.neuroscience.2015.02.036. [Epub ahead of print]
151. Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Progress in Neurobiology, 2004; 72(2):111-127.
152. Xu B, Shan M, Wang F, Deng Y, Liu W, Feng S, Yang TY, Xu ZF. Endoplasmic reticulum stress signaling involvement in manganese-induced nerve cell damage in organotypic brain slice cultures. Toxicology Letters, 2013; 222(3):239-246.
153. Milatovik D, Zaja-Milatovic S, Gupta RC, Yu Y, Aschner M. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicology and Applied Pharmacology, 2009; 240:219-225.
154. Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and biomarkers of lead exposure: A review. Reviews on Environmental Health, 2009; 24(1):15-45.
155. Eshel N, Tian J, Uchida N. Opening the black box: Dopamine, predictions, and learning. Trends in Cognitive Sciences, 2013; 17(9):430-431.
156. Schubert D, Martens GJM, Kolk SM. Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders. Molecular Psychiatry, 2013; 2014:1-15.
157. Chandravanshi LP, Shukla RK, Sultana S, Pant AB, Khanna VK. Early life arsenic exposure and brain dopaminergic alterations in rats. International Journal of Developmental Neuroscience, 2014; 38C:91-104.
158. Sofroniew MV. Astrogliosis. Cold Spring Harbor Perspectives in Biology, 2015; 7:a020420.
159. Zheng W. Toxicology of choroid plexus: Special reference to metal-induced neurotoxicities. Microscopy Research and Technique, 2001; 52(1):89-103.
160. Rooney AA, Boyles AL, Wolfe MS, Bucher JR, Thayer KA. Systematic review and evidence integration for literature-based environmental health science assessments. Environmental Health Perspectives, 2014; 122(7):711-718.
161. Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria of published animal studies: A systematic review. Environmental Health Perspectives, 2013; 121(9):985-992. Available at: http://dx.doi.org/10.1289/ehp.1206389.
162. Tricco AC, Tetzlaff J, Moher D. The art and science of knowledge synthesis. Journal of Clinical Epidemiology, 2011; 64:11-20.
163. Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M. Adverse outcome pathway (AOP) development I: Strategies and principles. Toxicological Sciences, 2015; 142(2):312-320.
164. Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M. Adverse outcome pathway development II: Best practices. Toxicological Sciences, 2014; 142(2):321-330.
165. Bal-Price A, Crofton KM, Sachana M, Shafer TJ, Behl M, Forsby A, Hargreaves A, Landesmann B, Lein PJ, Louisse J, Monnet-Tschudi F, Paini A, Rolaki A, Schrattenholz A, Suñol C, van Thriel C, Whelan M, Fritsche E. Putative adverse outcome pathways relevant to neurotoxicity. Critical Reviews in Toxicology, 2015; 45(1):83-91.
166. Rubenstein JLR. Annual research review: Development of the cerebral cortex: Implications for neurodevelopmental disorders. Journal of Child Psychology and Psychiatry, 2011; 52(4):339-355.
167. Lucas RM, McMichael AJ. Association or causation: Evaluating links between "environment and disease." Bulletin of World Health Organization, 2005; 83(10):792-795. Available at: http://www.who.int/bulletin/volumes/83/10/792.pdf.
168. Allen TE, Goodman JM, Gutsell S, Russell PJ. Defining molecular initiating events in the adverse outcome pathway framework for risk assessment. Chemical Research in Toxicology, 2014; 27(12):2100-12.
169. Patlewicz G, Simon TW, Rowlands JC, Budinsky RA, Becker RA. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Regulatory Toxicology and Pharmacology, 2015; 71(3):463-477.
170. Billionnet C, Sherrill D, Annesi-Maesano I, Study G. Estimating the health effects of exposure to multi-pollutant mixture. Annals of Epidemiology, 2012; 22(2):126-141.
171. Conolly RB. Biologically motivated quantitative models and the mixture toxicity problem. Toxicological Sciences, 2001; 63(1):1-2.
172. Cory-Slechta DA. Studying toxicants as single chemicals: Does this strategy adequately identify neurotoxic risk? Neurotoxicology, 2005; 26(4):491-510.
173. Sexton K, Linder SH. Cumulative risk assessment for combined health effects from chemical and nonchemical stressors. American Journal of Public Health, 2011; 101:S81-S88.
174. Yang RS, Dennison JE. Initial analyses of the relationship between "thresholds" of toxicity for individual chemicals and "interaction thresholds" for chemical mixtures. Toxicology and Applied Pharmacology, 2007; 223(2):133-138.
175. Gennings C, Carter WH. Utilizing concentration-response data from individual components to detect statistically significant departures from additivity in chemical mixtures. Biometrics, 1995; 51(4):1264-1277.
176. Taylor MD, Clewell HJ, 3rd, Andersen ME, Schroeter JD, Yoon M, Keene AM, Dorman DC. Update on a pharmacokinetic-centric alternative tier II program for MMT-part II: Physiologically based pharmacokinetic modeling and manganese risk assessment. Journal of Toxicology, 2012; Article ID 791431, doi:10.1155/2012/791431.
177. Teeguarden JG, Dorman DC, Covington DC, Clewell III HJ, Andersen ME. Pharmacokinetic modeling of manganese. I. Dose dependencies of uptake and elimination. Journal of Toxicology and Environmental Health Part A, 2007; 70:1493-1504.
178. Hays SM, Aylward LL, Gagne M, Nong A, Krishnan K. Biomonitoring equivalents for inorganic arsenic. Regulatory Toxicology and Pharmacology, 2010; 58(1):1-9.
179. El-Masri HA, Kenyon EM. Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites. Journal of Pharmacokinetics and Pharmacodynamics, 2008; 35(1):31-68.
180. Choudhury H, Harvey T, Thayer WC, Lockwood TF, Stiteler WM, Goodrum PE, Hassett JM, Diamond GL. Urinary cadmium elimination as a biomarker of exposure for evaluating a cadmium dietary exposure-biokinetics model. Journal of Toxicology and Environmental Health, 2001; 63(5):321-350.
181. Ruiz P, Fowler BA, Osterloh JD, Fisher J, Mumtaz M. Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants-Metals. SAR and QSAR in Environmental Research, 2010; 21(7-8):603-618.
182. Kjellström T, Nordberg GF. A kinetic model of cadmium metabolism in the human being. Environmental Research, 1978; 16(1-3):248-269.
183. Haddad S, Tardif R, Viau C, Krishnan K. A modeling approach to account for toxicokinetic interactions in the calculation of biological hazard index for chemical mixtures. Toxicology Letters, 1999; 108(2-3):303-308.
184. Haddad S, Béliveau M, Tardif R, Krishnan K. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures. Toxicological Sciences, 2001; 63(1):125-131.
185. Yoon M, Campbell JL, Andersen ME, Clewell HJ. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. Critical Reviews in Toxicology, 2012; 42(8):633-652.
186. Thomas RS, Black MB, Li L, Healy E, Chu TM, Bao W, Andersen ME, Wolfinger RD. A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. Toxicological Sciences, 2012; 128(2):398-417.
187. Wetmore BA, Wambaugh JF, Ferguson SS, Li L, Clewell HJ, III, Judson RS, Freeman K, Bao W, Sochaski MA, Chu T-M, Michael BB, Eric H, Brittany A, Melvin EA, Russell DW, Russell ST. Relative impact of incorporating pharmacokinetics on predicting in vivo hazard and mode of action from high-throughput in vitro toxicity assays. Toxicological Sciences, 2013; 132(2):327-346.
188. Breier JM, Radio NM, Mundy WR, Shafer TJ. Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicological Sciences, 2008; 105(1):119-133.